United Kingdom

People: TransUnion (TRU.N)

TRU.N on New York Stock Exchange

7:42pm BST
Change (% chg)

$0.72 (+0.96%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Peck, James 

Mr. James M. Peck is no longer Director of the Company effective on February 29, 2020. He is no longer President, Chief Executive Officer of the TransUnion effective on May 8, 2019. Mr. Peck joined the Company in December 2012 as President and Chief Executive Officer. Mr. Peck has more than 20 years of information management, global product development and engineering experience. He has led TransUnion through a transformation into a higher-growth, higher-margin business by setting and executing a strong strategy focused on enhancing the Company’s data, technology and analytics capabilities and achieving growth in key industry verticals and international markets. Prior to TransUnion, Mr. Peck was with Reed Elsevier, a FTSE 100 company, where he served as CEO of the LexisNexis Risk Solutions business from 2004-2012. Prior to 2004, Mr. Peck was the Senior Vice President and Chief Product Officer for the LexisNexis group. Previously, Mr. Peck was the Senior Vice President of Product Development with Celera Genomics, a bio-technology firm that sequenced the human genome. Prior to that, he spent a decade at LexisNexis in engineering and executive roles to manage and build information solutions. He also serves on the board of the Museum of Science and Industry, Chicago. Mr. Peck holds a bachelor’s degree from the University of Dayton and an M.B.A. from The Ohio State University.

Basic Compensation

Total Annual Compensation, USD 992,308
Restricted Stock Award, USD 9,036,690
Long-Term Incentive Plans, USD --
All Other, USD 2,235,120
Fiscal Year Total, USD 12,264,100

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 502,221 30,325,700.00
Name Fiscal Year Total

Leo Mullin


Christopher Cartwright


Todd Cello


Abhi Dhar


Steven Chaouki


John Danaher

As Of  31 Dec 2018